Learn more

MD HEALTHCARE INC

Overview
  • Total Patents
    270
  • GoodIP Patent Rank
    5,414
  • Filing trend
    0.0%
About

MD HEALTHCARE INC has a total of 270 patent applications. It increased the IP activity by 0.0%. Its first patent ever was published in 2015. It filed its patents most often in Republic of Korea, WIPO (World Intellectual Property Organization) and China. Its main competitors in its focus markets pharmaceuticals, biotechnology and foods and drinks are QINGDAO YANGSHEN BIOLOGICAL MEDICINE CO LTD, TELOMERE DIAGNOSTICS INC and PHARMACOGENETICS LTD.

Patent filings per year

Chart showing MD HEALTHCARE INCs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Kim Yoon-Keun 171
#2 Yoon Keun Kim 79
#3 Kim Yoon Keun 20
#4 Jeon Seong Gyu 13
#5 Han Pyung Lim 10
#6 Ban Changill 7
#7 Jee Young Koo 7
#8 Pyun Bok Yang 7
#9 Park Hyun-Taek 6
#10 Kim Minhye 6

Latest patents

Publication Filing date Title
US2021008157A1 Nano-vesicles derived from genus cupriavidus bacteria and use thereof
WO2021049834A1 Method for diagnosing colorectal cancer on basis of metagenome and metabolite of extracellular vesicles
WO2021049798A1 Lung disease diagnostic method based on antibodies against microorganism-derived vesicles
WO2021006523A1 Method for diagnosing brain tumor through bacterial metagenomic analysis
KR20210006282A Method for diagnosis of brain tumor using analysis of bacteria metagenome
WO2020218868A1 Streptococcus pyogenes bacteria-derived protein, and use thereof
KR20200125465A Proteins derived from Streptococcus pyogenes bacteria and Use thereof
KR20210030846A Method for diagnosing colorectal cancer based on metagenome and metabolome of extracellular vesicles
KR20210030845A Method for diagnosis of lung disease based on antibodies for microbial-derived vesicles
US2020206282A1 Method for treating inflammation or cancer using extracellular vesicles derived from Lactobacillus paracasei
WO2020166868A1 Nanovesicles derived from bacteria of genus rothia, and use thereof
KR20200099473A Nanovesicles derived from Rothia bacteria and Use thereof
WO2020145661A1 Nanovesicles derived from bacteria of genus deinococcus, and use thereof
WO2020145663A1 Nanovesicles derived from bacteria of genus rhodococcus, and use thereof
KR20200086639A Nanovesicles derived from Rhodococcus bacteria and Use thereof
KR20200086638A Nanovesicles derived from Deinococcus bacteria and Use thereof
WO2020122448A1 Weissella bacteria-derived nanovesicle and use thereof
WO2020122449A1 Nano-vesicle derived from corynebacterium sp. bacteria and use thereof
WO2020122450A1 Nanovesicles derived from bacteria of genus sphingomonas and uses of same
KR20200070989A Nanovesicles derived from Weissella bacteria and Use thereof